End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.06 CNY | +1.01% | +19.49% | -11.64% |
Apr. 25 | Yifan Unit's Allergy Drug Passes China Regulatory Test, Stock Price Jumps | MT |
Apr. 25 | Yifan Pharmaceutical's Unit Gets Nod to Register Nimodipine Injection | MT |
Sales 2024 * | 5.22B 721M | Sales 2025 * | 6.5B 898M | Capitalization | 15.89B 2.19B |
---|---|---|---|---|---|
Net income 2024 * | 560M 77.35M | Net income 2025 * | 742M 102M | EV / Sales 2024 * | 3.04 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.44 x |
P/E ratio 2024 * |
28.4
x | P/E ratio 2025 * |
21.5
x | Employees | 4,230 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.82% |
1 day | +1.01% | ||
1 week | +19.49% | ||
Current month | +17.87% | ||
1 month | +18.84% | ||
3 months | +5.41% | ||
6 months | +0.46% | ||
Current year | -11.64% |
Managers | Title | Age | Since |
---|---|---|---|
Xian Feng Cheng
CHM | Chairman | 56 | 14-10-14 |
Guo Han Xu
CHM | Chairman | 57 | 14-09-30 |
De Qi Feng
BRD | Director/Board Member | 45 | 16-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xian Feng Cheng
CHM | Chairman | 56 | 14-10-14 |
Yi Qun Ye
BRD | Director/Board Member | 51 | 14-10-14 |
Ben Yu Zhou
BRD | Director/Board Member | 51 | 14-10-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 13.06 | +1.01% | 16,210,880 |
24-04-25 | 12.93 | +2.13% | 18,631,340 |
24-04-24 | 12.66 | +5.32% | 32,231,680 |
24-04-23 | 12.02 | +5.81% | 18,538,010 |
24-04-22 | 11.36 | +3.93% | 14,487,100 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.64% | 2.19B | |
+20.81% | 43.34B | |
+20.44% | 21.96B | |
+11.60% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 002019 Stock